Genomictree Inc. (228760) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.028x

Based on the latest financial reports, Genomictree Inc. (228760) has a cash flow conversion efficiency ratio of -0.028x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.21 Billion ≈ $-2.18 Million USD) by net assets (₩115.31 Billion ≈ $78.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Genomictree Inc. market capitalisation for the company's overall valuation and market capitalisation.

Genomictree Inc. - Cash Flow Conversion Efficiency Trend (2020–2025)

This chart illustrates how Genomictree Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Genomictree Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genomictree Inc. ranked by their cash flow conversion efficiency. See how well can Genomictree Inc. service its debt to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Yuan Jen Enterprises Co Ltd TW:1725	-0.002x
Security National Financial NASDAQ:SNFCA	86.720x
Legal & General Group PLC LSE:LGEN	-1.135x
Genova Property Group AB ST:GPG	0.019x
TMC Life Sciences Bhd KLSE:0101	0.010x
Surrozen Inc NASDAQ:SRZN	0.034x
Hillgrove Resources Ltd AU:HGO	0.266x
Autosports Group Ltd AU:ASG	0.043x

Annual Cash Flow Conversion Efficiency for Genomictree Inc. (2020–2025)

The table below shows the annual cash flow conversion efficiency of Genomictree Inc. from 2020 to 2025. View Genomictree Inc. stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩115.31 Billion ≈ $78.14 Million	₩-10.19 Billion ≈ $-6.91 Million	-0.088x	+19.40%
2024-12-31	₩124.32 Billion ≈ $84.25 Million	₩-13.63 Billion ≈ $-9.24 Million	-0.110x	-26.02%
2023-12-31	₩125.03 Billion ≈ $84.73 Million	₩-10.88 Billion ≈ $-7.37 Million	-0.087x	-317.38%
2022-12-31	₩107.05 Billion ≈ $72.55 Million	₩4.29 Billion ≈ $2.90 Million	0.040x	+160.38%
2021-12-31	₩115.10 Billion ≈ $78.00 Million	₩-7.63 Billion ≈ $-5.17 Million	-0.066x	+38.01%
2020-12-31	₩95.26 Billion ≈ $64.55 Million	₩-10.19 Billion ≈ $-6.90 Million	-0.107x	--

About Genomictree Inc.

KQ:228760 Korea Biotechnology

Market Cap

$194.66 Million

₩287.24 Billion KRW

Market Cap Rank

#16746 Global

#640 in Korea

Share Price

₩11960.00

Change (1 day)

+17.37%

52-Week Range

₩10070.00 - ₩32000.00

All Time High

₩38550.00